Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 19/20 | 0.62 |
| ▸ | HTR2C | P28335 | 17/20 | 0.62 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5244602 | 0.94 | HTR2A (0.67) | HTR2AHTR2CHSP90AA1HSP90AB1 | |
| SCHEMBL5245206 | 0.91 | HTR2A (0.75) | HTR2AHTR2C | |
| SCHEMBL5245201 | 0.90 | HTR2A (0.72) | HTR2AHTR2C | |
| SCHEMBL5244163 | 0.88 | HTR2A (0.62) | HTR2AHTR2C | |
| SCHEMBL1166781 | 0.86 | HTR2A (0.83) | HTR2AHTR2C | |
| SCHEMBL5242469 | 0.84 | HTR2A (0.61) | HTR2AHTR2C | |
| SCHEMBL5242230 | 0.83 | HTR2A (0.57) | HTR2AHTR2C | |
| SCHEMBL5243983 | 0.83 | HTR2A (0.75) | HTR2AHTR2C | |
| SCHEMBL5244625 | 0.83 | HTR2A (0.58) | HTR2AHTR2C | |
| SCHEMBL5245751 | 0.82 | HTR2A (0.59) | HTR2AHTR2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1833799-A2 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT-2a SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | Arena Pharmaceuticals, Inc. (US) | 2007-09-19 | — | — | EP | disclosed |
| WO-2006055734-A2 | 3-PHENYL-PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2006-05-26 | — | — | WO | disclosed |